Bayer to bring five mid-stage drugs into Phase III by 2015
FRANKFURT (Reuters) - German drugmaker Bayer said it aims to bring its five most advanced mid-stage drug development projects into the third and last phase of testing on humans by 2015.
The five experimental drugs in the areas of oncology, cardiology and women's health are currently in Phase I and II of testing, Bayer said in a statement on Tuesday.
Bayer executives will make presentations to analysts later on Tuesday.
- Radar showed missing plane may have turned back: Malaysia military
- Malaysian jetliner may have turned back before vanishing |
- Malaysian plane presumed crashed; questions over false IDs |
- Malaysian jet's disappearance among rarest of aviation disasters